Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury.
Excessive mechanical stress is a key component of ventilator-associated lung injury, resulting in profound vascular leak and an intense inflammatory response. To extend our in vitro observations concerning the barrier-protective effects of the lipid growth factor sphingosine 1-phosphate (Sph 1-P), we assessed the ability of Sph 1-P to prevent regional pulmonary edema accumulation in clinically relevant rodent and canine models of acute lung injury induced by combined intrabronchial endotoxin administration and high tidal volume mechanical ventilation. Intravenously delivered Sph 1-P significantly attenuated both alveolar and vascular barrier dysfunction while significantly reducing shunt formation associated with lung injury. Whole lung computed tomographic image analysis demonstrated the capability of Sph 1-P to abrogate significantly the accumulation of extravascular lung water evoked by 6-hour exposure to endotoxin. Axial density profiles and vertical density gradients localized the Sph 1-P response to transitional zones between aerated and consolidated lung regions. Together, these results indicate that Sph 1-P represents a novel therapeutic intervention for the prevention of pulmonary edema related to inflammatory injury and increased vascular permeability.
Division of Pulmonary and Critical Care Medicine, Center for Translational Respiratory Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.
Bryan J
BJ
McVerry
Xinqi
X
Peng
Paul M
PM
Hassoun
Saad
S
Sammani
Brett A
BA
Simon
Joe G N
JG
Garcia
D000208:Acute Disease; D000818:Animals; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry; D002199:Capillary Permeability / Q000187:drug effects*; D004195:Disease Models, Animal; D004285:Dogs; D015633:Extravascular Lung Water / Q000187:drug effects*; D005260:Female; D016014:Linear Models; D055370:Lung Injury; D008246:Lysophospholipids / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D011336:Probability; D011652:Pulmonary Circulation / Q000502:physiology; D011654:Pulmonary Edema / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D012121:Respiration, Artificial / Q000009:adverse effects* / Q000379:methods; D012129:Respiratory Function Tests; D012720:Severity of Illness Index; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D014057:Tomography, X-Ray Computed
D008246:Lysophospholipids; C060506:sphingosine 1-phosphate; D013110:Sphingosine